Arqule, Inc. - ARQL- Quotes & Financials

Home » Directory » Pharmaceuticals & Biotechnology » Biotechnology » Arqule, Inc. » Quote & Financials



Company Financials
StreetInsider.com - UBS Downgrades ArQule (ARQL) to Neutral
UBS downgrades ArQule (Nasdaq: ARQL) from Buy to Neutral. ... ArQule, Inc., a clinical-stage biotechnology company, engages in the research and development ...
http://www.streetinsider.com/Downgrades/UBS+Downgrades+ArQule+(ARQL)+to+Neutral/4538...
ArQule's Drug Discovery Platform (NASDAQ:ARQL) | Stock Market News ...
Nov 17, 2009 ... ArQule Inc (NASDAQ:ARQL) has presented their data at the AACR-NCI-EORTC meeting in Boston which clearly demonstrates the capabilities of ...
http://www.straightstocks.com/stock-watch/arqule%E2%80%99s-drug-discovery-platform-n...
ARQL: Summary for ArQule, Inc.- Yahoo! Finance
Get detailed information on ArQule, Inc. (ARQL) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, ...
http://finance.yahoo.com/q?s=ARQL
ARQULE Stock Quote | ARQL Company Stock Market Quotes ...
ARQULE. A clinical-stage biotechnology company, which is engaged in the research and ... Drug Discovery Capabilities of ArQule Kinase Inhibitor Platform ...
http://finance.paidcontent.org/V?Page=QUOTE&Ticker=ARQL
Related Business Topics
click here
A-Z Arqule, Inc. Provider Directory
0-9 | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
A
ArQule
At ArQule, we unite innovative thinking with proprietary, patented technologies to design and produce molecules that will become the medicines of the future.
www.arqule.com

Overview  |  Profile  |  News  |  Quote & Financials